These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 22886612)

  • 1. The treatment of lower urinary tract symptoms in patients with multiple sclerosis: a systematic review.
    Tubaro A; Puccini F; De Nunzio C; Digesu GA; Elneil S; Gobbi C; Khullar V
    Curr Urol Rep; 2012 Oct; 13(5):335-42. PubMed ID: 22886612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Consensus document on the multidisciplinary management of neurogenic lower urinary tract dysfunction in patients with multiple sclerosis.
    Medina-Polo J; Adot JM; Allué M; Arlandis S; Blasco P; Casanova B; Matías-Guiu J; Madurga B; Meza-Murillo ER; Müller-Arteaga C; Rodríguez-Acevedo B; Vara J; Zubiaur MC; López-Fando L
    Neurourol Urodyn; 2020 Feb; 39(2):762-770. PubMed ID: 31943361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Catheterization for treating neurogenic lower urinary tract dysfunction in patients with multiple sclerosis: A systematic review. A report from the Neuro-Urology Promotion Committee of the International Continence Society (ICS).
    Tornic J; Sartori AM; Gajewski JB; Cox A; Schneider MP; Youssef NA; Mordasini L; Chartier-Kastler E; Bachmann LM; Kessler TM
    Neurourol Urodyn; 2018 Nov; 37(8):2315-2322. PubMed ID: 29917273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of lower urinary tract dysfunction in multiple sclerosis: a systematic review and Turkish consensus report.
    Çetinel B; Tarcan T; Demirkesen O; Özyurt C; Şen İ; Erdoğan S; Siva A
    Neurourol Urodyn; 2013 Nov; 32(8):1047-57. PubMed ID: 23757108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Consensus guidelines on the neurologist's role in the management of neurogenic lower urinary tract dysfunction in multiple sclerosis.
    De Ridder D; Van Der Aa F; Debruyne J; D'hooghe MB; Dubois B; Guillaume D; Heerings M; Ilsbroukx S; Medaer R; Nagels G; Seeldrayers P; Van Landegem W; Willekens B; Zicot AF
    Clin Neurol Neurosurg; 2013 Oct; 115(10):2033-40. PubMed ID: 23880016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Neuro-urological diagnostics and treatment of non-traumatic/degenerative neurogenic lower urinary tract dysfunction exemplified by multiple sclerosis].
    Kurze I; Jaekel AK
    Aktuelle Urol; 2024 Aug; 55(4):315-325. PubMed ID: 38653466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The overactive bladder in multiple sclerosis.
    Fingerman JS; Finkelstein LH
    J Am Osteopath Assoc; 2000 Mar; 100(3 Suppl):S9-12. PubMed ID: 10763312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Barriers experienced by patients with multiple sclerosis in seeking care for lower urinary tract symptoms.
    Brucker BM; Nitti VW; Kalra S; Herbert J; Sadiq A; Utomo P; Aponte MM
    Neurourol Urodyn; 2017 Apr; 36(4):1208-1213. PubMed ID: 27548624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of bladder problems in patients with multiple sclerosis.
    Unsworth J; Freeman L
    Br J Community Nurs; 2000 May; 5(5):230, 232, 234, 236-8. PubMed ID: 12271205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurogenic lower urinary tract dysfunction in the early disease phase of paediatric multiple sclerosis.
    Scheepe JR; Wong YY; van Pelt ED; Ketelslegers IA; Catsman-Berrevoets CE; van den Hoek J; Hintzen RQ; Neuteboom RF
    Mult Scler; 2016 Oct; 22(11):1490-1494. PubMed ID: 26589894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Secondary and tertiary treatments for multiple sclerosis patients with urinary symptoms.
    Tracey JM; Stoffel JT
    Investig Clin Urol; 2016 Nov; 57(6):377-383. PubMed ID: 27847911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Challenges to Longitudinal Characterization of Lower Urinary Tract Dysfunction in Multiple Sclerosis.
    Kaplan TB; Gopal A; Block VJ; Suskind AM; Zhao C; Polgar-Turcsanyi M; Saraceno TJ; Gomez R; Santaniello A; Consortium S; Ayoubi NE; Cree BAC; Hauser SL; Weiner H; Chitnis T; Khoury S; Bove R
    Mult Scler Relat Disord; 2022 Jun; 62():103793. PubMed ID: 35461057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of intermittent catheterization on the quality of life of multiple sclerosis patients.
    Castel-Lacanal E; Gamé X; De Boissezon X; Guillotreau J; Braley-Berthoumieux E; Terracol C; Gasq D; Labrunee M; Viala F; Rischmann P; Clanet M; Marque P
    World J Urol; 2013 Dec; 31(6):1445-50. PubMed ID: 23292297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sacral neuromodulation for the treatment of neurogenic lower urinary tract dysfunction caused by multiple sclerosis: a single-centre prospective series.
    Engeler DS; Meyer D; Abt D; Müller S; Schmid HP
    BMC Urol; 2015 Oct; 15():105. PubMed ID: 26498275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pelvic floor muscle training adapted for urinary incontinence in multiple sclerosis: a randomized clinical trial.
    Pérez DC; Chao CW; Jiménez LL; Fernández IM; de la Llave Rincón AI
    Int Urogynecol J; 2020 Feb; 31(2):267-275. PubMed ID: 31183535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Usefulness of sacral nerve modulation in a series of multiple sclerosis patients with bladder dysfunction.
    Andretta E; Simeone C; Ostardo E; Pastorello M; Zuliani C
    J Neurol Sci; 2014 Dec; 347(1-2):257-61. PubMed ID: 25454644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravesical vanilloids for treating neurogenic lower urinary tract dysfunction in patients with multiple sclerosis: A systematic review and meta-analysis. A report from the Neuro-Urology Promotion Committee of the International Continence Society (ICS).
    Phé V; Schneider MP; Peyronnet B; Abo Youssef N; Mordasini L; Chartier-Kastler E; Bachmann LM; Kessler TM
    Neurourol Urodyn; 2018 Jan; 37(1):67-82. PubMed ID: 28618110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Follow-up of the neuro-urological patient: a systematic review.
    Averbeck MA; Madersbacher H
    BJU Int; 2015 Apr; 115 Suppl 6():39-46. PubMed ID: 25891319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Neuro-urological dysfunction of the lower urinary tract in CNS diseases: pathophysiology, epidemiology, and treatment options].
    Mehnert U; Nehiba M
    Urologe A; 2012 Feb; 51(2):189-97. PubMed ID: 22331072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurogenic lower urinary tract dysfunction: Clinical management recommendations of the Neurologic Incontinence committee of the fifth International Consultation on Incontinence 2013.
    Drake MJ; Apostolidis A; Cocci A; Emmanuel A; Gajewski JB; Harrison SC; Heesakkers JP; Lemack GE; Madersbacher H; Panicker JN; Radziszewski P; Sakakibara R; Wyndaele JJ
    Neurourol Urodyn; 2016 Aug; 35(6):657-65. PubMed ID: 27176559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.